The pharmaceutical sector of Saudi Chemical Holding Group represented by AJA Pharma and SITCO Pharma has signed an agreement with Russia’s Direct Investment Fund to cooperate on the Russian Coronavirus vaccine. Under the first phase of the agreement, the vaccine will be provided and distributed in Saudi Arabia. Under the second phase, the technologies for manufacturing the vaccine in the Kingdom will be transferred. The agreement also states the Direct Investment Fund will be represented by the Saudi Chemical Group Holding before the relevant government agencies in terms of registration and clinical studies. Full story
